IBC Life Sciences' 5th Annual International Conference on Anti-angiogenesis was held on November 12 & 13, 2007 in Boston, MA. With 8 keynote presentations and dedicated sessions on antibody therapeutics, signal transduction, integrins and vascular disrupting agents, attendees were able to get an update on new drugs and what makes an efficacious anti-angiogenic drug.

Here's what attendees had to say about the conference...

"Excellent forum for interacting with the leaders in Academia & Industry"
- Steven Brem, MD, Chief of NeuroSurgery, Moffit Cancer Center

"Excellent platform for networking; Good mix of Industry & Academic data on progress in the field of anti-angiogenic therapy (oncology)"
- C. Christner Albrecht, Senior Scientist, Jerini AG

"This conference was a useful way of getting me, a newcomer to the field, up to date quickly with the latest developments"
- Roger Melton, Director of Development, Morvus Technology

» See who attended the Anti-angiogenesis conference

Stay tuned for details about the 6th annual Anti-angiogenesis conference in 2008!